Trial design
The present study was an investigator-initiated, single center, parallel, open-labeled randomized controlled trial conducted in Thammasat University Hospital, Thailand, from July 2021 to June 2022. This study was approved by the Institutional Review Board of Thammasat University and was retrospectively registered with Thai Clinical Trial Registry number TCTR20210928001 (first posted date: 28/09/2021). The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.